Advancing Killer Cell Immunotherapy with Mark Frohlich
In this episode, we talk with Dr. Mark Frohlich, CEO of Indapta Therapeutics, a biotech company working to make cancer treatment safer, more effective, and more accessible.
In this episode, we talk with Dr. Mark Frohlich, CEO of Indapta Therapeutics, a biotech company working to make cancer treatment safer, more effective, and more accessible.
In part two of our conversation with Bruno Basso, professor at Michigan State University and co-founder of CIBO Technologies, we explore what it takes to scale scientific innovation into a venture-backed company.
In part one of this two-part episode, we talk with Bruno Basso, professor at Michigan State University and co-founder of CIBO Technologies, a company using advanced modeling to help farmers make smarter decisions that improve both productivity and environmental outcomes.
In this episode, we talk with Mike Klein, CEO of Genomenon, a genomics intelligence company helping researchers and clinicians make sense of vast amounts of genetic data.
In this episode we talk with James Klausner, professor of mechanical engineering at MSU and co-founder of Redoxblox, a startup developing thermochemical energy storage solutions.